ArticleFrontiers in immunology2017

Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.

Javier Rodríguez-Carrio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.